Lisuride treatment of focal dystonias

John Nutt, John Hammerstad, Julie Carter, Patricia L. deGarmo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Nine patients with various focal dystonias participated in a 12-week, double-blind, crossover comparison of the dopamine agonist, lisuride, and placebo. Lisuride produced mild objective and subjective improvement in six subjects, but the improvement was not sustained with continued therapy. Because the patients generally identified the active drug by side effects, biasing the study toward finding an effect, and because the benefits were mild and transient, we conclude that lisuride is of limited use in the treatment of focal dystonias.

Original languageEnglish (US)
Pages (from-to)1242-1243
Number of pages2
JournalNeurology
Volume35
Issue number8
StatePublished - 1985

Fingerprint

Lisuride
Dystonic Disorders
Dopamine Agonists
Drug-Related Side Effects and Adverse Reactions
Therapeutics
Placebos

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Nutt, J., Hammerstad, J., Carter, J., & deGarmo, P. L. (1985). Lisuride treatment of focal dystonias. Neurology, 35(8), 1242-1243.

Lisuride treatment of focal dystonias. / Nutt, John; Hammerstad, John; Carter, Julie; deGarmo, Patricia L.

In: Neurology, Vol. 35, No. 8, 1985, p. 1242-1243.

Research output: Contribution to journalArticle

Nutt, J, Hammerstad, J, Carter, J & deGarmo, PL 1985, 'Lisuride treatment of focal dystonias', Neurology, vol. 35, no. 8, pp. 1242-1243.
Nutt J, Hammerstad J, Carter J, deGarmo PL. Lisuride treatment of focal dystonias. Neurology. 1985;35(8):1242-1243.
Nutt, John ; Hammerstad, John ; Carter, Julie ; deGarmo, Patricia L. / Lisuride treatment of focal dystonias. In: Neurology. 1985 ; Vol. 35, No. 8. pp. 1242-1243.
@article{70b62e34edc64706b831ff2e4bb6eaef,
title = "Lisuride treatment of focal dystonias",
abstract = "Nine patients with various focal dystonias participated in a 12-week, double-blind, crossover comparison of the dopamine agonist, lisuride, and placebo. Lisuride produced mild objective and subjective improvement in six subjects, but the improvement was not sustained with continued therapy. Because the patients generally identified the active drug by side effects, biasing the study toward finding an effect, and because the benefits were mild and transient, we conclude that lisuride is of limited use in the treatment of focal dystonias.",
author = "John Nutt and John Hammerstad and Julie Carter and deGarmo, {Patricia L.}",
year = "1985",
language = "English (US)",
volume = "35",
pages = "1242--1243",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Lisuride treatment of focal dystonias

AU - Nutt, John

AU - Hammerstad, John

AU - Carter, Julie

AU - deGarmo, Patricia L.

PY - 1985

Y1 - 1985

N2 - Nine patients with various focal dystonias participated in a 12-week, double-blind, crossover comparison of the dopamine agonist, lisuride, and placebo. Lisuride produced mild objective and subjective improvement in six subjects, but the improvement was not sustained with continued therapy. Because the patients generally identified the active drug by side effects, biasing the study toward finding an effect, and because the benefits were mild and transient, we conclude that lisuride is of limited use in the treatment of focal dystonias.

AB - Nine patients with various focal dystonias participated in a 12-week, double-blind, crossover comparison of the dopamine agonist, lisuride, and placebo. Lisuride produced mild objective and subjective improvement in six subjects, but the improvement was not sustained with continued therapy. Because the patients generally identified the active drug by side effects, biasing the study toward finding an effect, and because the benefits were mild and transient, we conclude that lisuride is of limited use in the treatment of focal dystonias.

UR - http://www.scopus.com/inward/record.url?scp=0021859338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021859338&partnerID=8YFLogxK

M3 - Article

C2 - 3895034

AN - SCOPUS:0021859338

VL - 35

SP - 1242

EP - 1243

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 8

ER -